Upgrade to SI Premium - Free Trial

Canaccord Reiterates Buy Rating on STAAR Surgical (STAA)

July 16, 2026 4:54 PM
Canaccord analyst John Young reiterated a Buy rating and $32.00 price target on STAAR Surgical (NASDAQ: STAA).The analyst commented: "STAAR ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments